EX-2.1
from 8-K
150 pages
Agreement and Plan of Merger and Reorganization by and Among Mirum Pharmaceuticals, Inc., Bjork Merger Sub I, Inc., Bjork Merger Sub II, LLC, Bluejay Therapeutics, Inc. and Fortis Advisors LLC, as Stockholder Representative December 6, 2025
12/34/56
EX-2.1
from 8-K
85 pages
Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Asset Purchase Agreement by and Between Travere Therapeutics, Inc. and Mirum Pharmaceuticals, Inc. Dated as of July 16, 2023
12/34/56
